SCA
Spearhead Capital Advisors Portfolio holdings
AUM
$92.3M
1-Year Return
18.16%
This Quarter Return
+5.22%
1 Year Return
-18.16%
3 Year Return
+25.24%
5 Year Return
+54.04%
10 Year Return
–
AUM
$677M
AUM Growth
+$47.9M
(+7.6%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
2.66%
Top 10 Holdings %
Top 10 Hldgs %
30.54%
Holding
223
New
55
Increased
84
Reduced
41
Closed
38
Top Buys
| 1 |
Roper Technologies
ROP
|
$9.09M |
| 2 |
Costco
COST
|
$8.8M |
| 3 |
Consolidated Edison
ED
|
$3.24M |
| 4 |
Procter & Gamble
PG
|
$2.85M |
| 5 |
Hormel Foods
HRL
|
$2.22M |
Top Sells
| 1 |
AT&T
T
|
$9.9M |
| 2 |
Coca-Cola
KO
|
$6.3M |
| 3 |
General Dynamics
GD
|
$5.97M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
$4.66M |
| 5 |
Vanguard Small-Cap Growth ETF
VBK
|
$4.25M |
Sector Composition
| 1 | Technology | 14.06% |
| 2 | Healthcare | 12.64% |
| 3 | Consumer Staples | 11.38% |
| 4 | Financials | 9.76% |
| 5 | Communication Services | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
BioLife Solutions
BLFS
$1.2B
| $347K | 0.05% |
+9,642
| New | +$347K |
|
|
EVBG
127
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $347K | 0.05% |
2,862
+598
| +26% | +$72.5K |
|
128
Medifast
MED
$154M
| $345K | 0.05% |
1,630
-749
| -31% | -$159K |
|
129
Enphase Energy
ENPH
$4.71B
| $344K | 0.05% |
+2,122
| New | +$344K |
|
130
Alnylam Pharmaceuticals
ALNY
$59.4B
| $343K | 0.05% |
2,427
+308
| +15% | +$43.5K |
|
131
Cerus
CERS
$245M
| $343K | 0.05% |
+57,134
| New | +$343K |
|
132
EverQuote
EVER
$829M
| $342K | 0.05% |
+9,427
| New | +$342K |
|
133
NVIDIA
NVDA
$4.16T
| $341K | 0.05% |
25,520
+1,320
| +5% | +$17.6K |
|
134
Trade Desk
TTD
$25.4B
| $341K | 0.05% |
5,230
-3,210
| -38% | -$209K |
|
135
Corcept Therapeutics
CORT
$7.41B
| $338K | 0.05% |
14,205
-3,643
| -20% | -$86.7K |
|
136
Axon Enterprise
AXON
$57.3B
| $337K | 0.05% |
+2,365
| New | +$337K |
|
137
CrowdStrike
CRWD
$102B
| $334K | 0.05% |
+1,831
| New | +$334K |
|
138
Ocular Therapeutix
OCUL
$2.22B
| $333K | 0.05% |
+20,281
| New | +$333K |
|
139
General Motors
GM
$55.1B
| $332K | 0.05% |
+5,777
| New | +$332K |
|
|
AVLR
140
DELISTED
Avalara, Inc.
AVLR
| $331K | 0.05% |
2,481
-198
| -7% | -$26.4K |
|
141
Neurocrine Biosciences
NBIX
$13.6B
| $331K | 0.05% |
3,405
+1,077
| +46% | +$105K |
|
142
Zoom
ZM
$24.8B
| $331K | 0.05% |
+1,030
| New | +$331K |
|
143
BlackLine
BL
$3.27B
| $329K | 0.05% |
3,036
-513
| -14% | -$55.6K |
|
144
Peloton Interactive
PTON
$3.3B
| $329K | 0.05% |
+2,925
| New | +$329K |
|
145
Okta
OKTA
$15.9B
| $328K | 0.05% |
1,490
-194
| -12% | -$42.7K |
|
146
ACM Research
ACMR
$1.71B
| $326K | 0.05% |
+12,111
| New | +$326K |
|
147
Vanguard Materials ETF
VAW
$2.85B
| $326K | 0.05% |
1,883
+26
| +1% | +$4.5K |
|
148
Zscaler
ZS
$41.5B
| $325K | 0.05% |
1,896
-1,731
| -48% | -$297K |
|
|
BLUE
149
DELISTED
bluebird bio
BLUE
| $322K | 0.05% |
+824
| New | +$322K |
|
150
CareDx
CDNA
$675M
| $322K | 0.05% |
4,735
-5,308
| -53% | -$361K |
|